Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
6
Number of overlapping holdings
20.0%
% of MEDX's 30 holdings also in XPH
15.0%
% of XPH's 40 holdings also in MEDX
Overlap by Weight
Sector Drift (MEDX minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in MEDX |
Weight in XPH |
Overlap | |
---|---|---|---|---|
MERCK & CO. INC. | 5.2% | 5.1% | 5.1% | |
ELI LILLY & CO | 14.9% | 4.7% | 4.7% | |
JOHNSON & JOHNSON | 5.2% | 4.6% | 4.6% | |
BRISTOL-MYERS SQUIBB CO | 5.3% | 4.5% | 4.5% | |
PFIZER INC | 4.1% | 4.8% | 4.1% |
Position Highlights (Non-Overlapping Exposures)
MEDX Overweight Relative to XPH
ELI LILLY & CO | 10.2% | |
ABBVIE INC | 7.8% | |
NOVARTIS AG-ADR | 5.5% | |
AMGEN INC | 5.5% | |
ASTRAZENECA PLC-SPONS ADR | 5.2% | |
REGENERON PHARMACEUTICALS | 3.9% | |
BIOGEN IDEC INC | 3.7% | |
CRISPR THERAPEUTICS AG | 3.6% | |
ALKERMES PLC | 3.4% | |
IONIS PHARMACEUTICALS, INC. | 3.1% |
MEDX Underweight Relative to XPH
INTRA-CELLULAR THERAPIES INC | -5.3% | |
PERRIGO CO | -5.0% | |
CATALENT INC | -4.9% | |
ORGANON & CO. | -4.8% | |
JAZZ PHARMACEUTICALS PLC | -4.7% | |
ROYALTY PHARMA PLC CLASS A | -4.6% | |
AXSOME THERAPEUTICS, INC. | -4.6% | |
VIATRIS, INC. | -4.3% | |
ZOETIS INC | -4.0% | |
ELANCO ANIMAL HEALTH, INC. | -3.9% |